HF
LMDXW

HRT Financial’s LumiraDx Limited Warrant LMDXW Stock Holding History

HRT Financial’s Portfolio LMDXW Stock Details LMDXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,797
Closed – – 3410
2022
Q4 		$0 Sell
14,797
-23,345
-61% -$3.19K ﹤0.01% 3421
2022
Q3 		$4K Sell
38,142
-7,639
-17% -$2.54K ﹤0.01% 2617
2022
Q2 		$41K Sell
45,781
-2,982
-6% -$2.58K ﹤0.01% 2533
2022
Q1 		$39K Hold
48,763
– – ﹤0.01% 2771
2021
Q4 		$69K Buy
48,763
+113
+0.2% +$182 ﹤0.01% 2808
2021
Q3 		$61K Buy
+48,650
New +$56.4K ﹤0.01% 3012

Other funds holding LMDXW

CH
CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

HRT Financial's LMDXW Position: Q1 2023 in Review

HRT Financial sold out of LumiraDx Limited Warrant (LMDXW) in Q1 2023, closing a stake of 14,797 shares.

HRT Financial first reported a position in LMDXW in Q3 2021 and held it in 6 quarters. The position peaked at $69K in Q4 2021. 15 funds tracked by Wall St. Rank hold LMDXW as of Q1 2023.

  • HRT Financial reported no remaining LumiraDx Limited Warrant position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 14,797 LumiraDx Limited Warrant shares in Q1 2023.
  • HRT Financial first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 6 quarters.
  • HRT Financial's LumiraDx Limited Warrant position peaked at $69K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.